麻豆传媒

Frederick, MD USA

Our 麻豆传媒 on 麻豆传媒
View All >

麻豆传媒: 6809344007482_CCHFfalsecoloredmerge.jpg

LifeArc Joins Transatlantic Collaboration to Develop a Treatment for Crimean-Congo Hemorrhagic Fever

A new transatlantic collaboration between the U.S. Army Medical Research Institute of Infectious Diseases (USAMRIID) and LifeArc will look to develop an affordable and accessible monoclonal antibody therapeutic for Crimean-Congo Hemorrhagic Fever...
23-Apr-2025 6:30 PM EDT Add to Favorites

麻豆传媒: 67f5607127d28_GP38Triggering.png

Researchers鈥� Study Show Advancements in GP38 Contributions to CCHFV and Monoclonal Antibody Therapies

A recent study published in Science Translational Medicine involving scientists from the U.S. Army Medical Research Institute of Infectious Diseases in collaboration with scientists from the Albert Einstein College of Medicine and the University of...
8-Apr-2025 9:15 PM EDT Add to Favorites

Army and Illinois researchers design, test protein that may lead to COVID-19 therapeutic

A novel receptor protein that binds to the SARS-CoV-2 virus and prevents it from entering cells may hold promise for treating COVID-19 and other coronavirus-related diseases, according to research published online Aug. 4 in the journal SCIENCE.
17-Aug-2020 3:40 PM EDT Add to Favorites

Ebola Virus Genome Provides Clues to Repeated Disease 'Flare-Ups' in Western Africa

Ebola virus samples taken from patients in Liberia in June 2015 are strikingly similar in their genetic makeup to other Ebola virus sequences from Western Africa, according to research published online today in the journal Science Advances. The...
29-Apr-2016 3:05 PM EDT Add to Favorites


See All News

Our Experts on News

Our experts are coming soon...

About

Since 1969, USAMRIID has provided leading edge medical capabilities to deter and defend against current and emerging biological threat agents. The Institute is the only laboratory in the Department of Defense equipped to safely study highly hazardous pathogens requiring maximum containment at Biosafety Level 4.

Research conducted at USAMRIID leads to vaccines, drugs, diagnostics, and training programs that protect both Warfighters and civilians. The Institute's unique science and technology base serves not only to address current threats to our Armed Forces but is an essential element in the medical response to any future biological threats that may confront our nation.

USAMRIID is a subordinate laboratory of the U.S. Army Medical Research and Development Command.

Experts

Facebook

close
0.33311